U.S. Army Medical Research and Materiel Command &
Fort Detrick Public Affairs/Marketing Office, Fort Detrick, Maryland

January 17, 2003

Department of Defense Breast Cancer Research Program Announces Concept Awards

Points of Contact:
Richard H. Kenyon, Ph.D., BCRP Program Manager
Gail Whitehead, Public Affairs Coordinator, phone 301-619-7071

Due to the overwhelming response to the fiscal year 1999 Concept Awards and the outstanding success reported by Concept Award recipients at the September 2002 Era of Hope meeting, the Department of Defense (DOD) Breast Cancer Research Program (BCRP) intends to re-announce this award mechanism. The BCRP plans to announce a $16M initiative to support Concept Awards on or about January 27, 2003.

Concept Awards are intended to fund an initial concept or theory that could give rise to a testable hypothesis within breast cancer research. The Congressionally Directed Medical Research Programs (CDMRP) plans to solicit electronic submissions for short (approximately one-page) Concept Award proposals. These awards can be requested for $75,000 in direct costs over a 12-month performance period, plus indirect costs as appropriate. The receipt deadline is planned for March 10, 2003. These awards will be reviewed and negotiated expeditiously so that research dollars will be available no later than September 30, 2003.

Concept Awards encourage the exploration of untested, innovative questions in breast cancer. Proposals should postulate a new paradigm, challenge existing paradigms, or examine an existing problem from a new perspective. Projects involving human subjects, human cell lines, or human specimens will not be supported unless they are exempt under 32 CFR 219.101(b)(4).1 Studies that do not qualify for exempt status during review at any level will be administratively withdrawn and will not be funded.

Please use the "contact" button above to request e-mail notification of this and all funding opportunities in this program, or to notify the CDMRP of your change of e-mail address to receive notifications.

1Title 32, Code of Federal Regulations, Part 219, Section 101(b)(4).

Research involving collection or study of existing data, documents, records, pathological specimens, or diagnostic specimens, if these sources are publicly available or if the information is recorded by the investigator in such a manner that subjects cannot be identified, is considered to be exempt under 32 CFR 219.101(b)(4). For additional information, refer to the document Research Involving Human Subjects and/or Anatomical Substances that will be available on the CDMRP web site at by April 2003.